Bloomberg Asian markets including China continue to show growing demand for high quality dietary supplements despite Covid-related disruptions and the general economic downturn, according to Australian vitamin manufacturer Blackmores Ltd. The company expects spending on vitamins and supplements to remain resilient to economic slowdowns, CEO Alastair Symington said in an interview with Bloomberg Television.

  Bloomberg Billionaire Guo Guangchang’s Shanghai Fosun Pharmaceutical Group Co is considering a sale of Indian drugmaker Gland Pharma Ltd after receiving interest from potential buyers, people familiar with the matter said. Fosun Pharma, a listed arm of Chinese conglomerate Fosun International Ltd, has been working with an adviser as it informally gauges interest in its controlling stake in Gland, ...

  Bloomberg Taiwan cut its 2022 growth forecast for the third time this year as the global demand slowdown and rising geopolitical tensions with China prove tough to navigate. Gross domestic product is likely to grow 3.06% for the year, the cabinet’s statistics department said. That’s lower than the last formal estimate of 3.76% given in August. The official 2023 ...